Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

NCT03505931 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03505931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03505931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2018
Completion date
April 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia (rutherford category 4 or 5), moderate or severe claudication (rutherford category 2 or 3), symptomatic peripheral artery disease with femoropopliteal lesions